Emergent BioSolutions recently reported strong third-quarter 2025 results, with revenue of US$231.1 million and net income of US$51.2 million, and raised its full-year guidance for both revenue and ...

Emergent BioSolutions signed a $65 million contract to supply NARCAN® Nasal Spray to Ontario's Naloxone Program for opioid overdose prevention. Emergent BioSolutions Inc. has announced a three-year ...

Shares of Emergent BioSolutions jumped 18% in after-hours trading after the company posted stronger-than-expected Q3 results ...

Starting July 1, 2025, additional opioid overdose response tools will be available to continue addressing evolving patient and customer needs to combat public health crisis GAITHERSBURG, Md., July 02, ...

GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and ...

A person who has overdosed on fentanyl may experience small pupils, skin discoloration, and slowed breathing.

Illicit drug overdoses and the deaths they cause are trending down this year, despite spikes in a handful of states, ...

Intranasal delivery of Naloxone presents several advantages, including ease of administration, eliminating the need for trained medical personnel, reduced risk of needlestick injuries and increased ...

The US Food and Drug Administration (FDA) has granted final approval for the first generic naloxone hydrochloride nasal spray (Narcan, Teva Pharmaceuticals) that can stop or reverse the effects of an ...

A Denton music venue unveiled a vending machine Tuesday that will give away free doses of Narcan to anyone who needs them. Narcan is the brand name for a nasal spray containing naloxone, a medicine ...